RE:Article about RVX & others in Oncology Discovery Jan 15LongRVXer.
Thanks. I scanned this quickly and have saved it to study. To me it is just another reinforcement of how advanced RVX is and it bodes extremely well for Zenith Epigenetics, at least if they are as far ahead in this field as Don claims, and while I've had my doubts and frustrations, I'm beginning to believe it is true and any company that finds themselves in catch up mode will find very attractive but I think that NGN and Eastern had the prescience in this case.
One thing that is good about these companies is that there is not two classes of shares.
It does seem that epigenetics will play a very large role in the future of health care and many diseases including individualized patient treatment.
As I recall RVX started into this about 10 years ago at the direction of Dr Wong and others. No wonder that Eastern (Ken Dart) and NGN are so involved with RVX and Zenith.
Thanks again for the valuable post.
Toinv :)